Just like allergy sufferers. And they are on the rise. For many people allergies can range from sniffling and sneezing to skin rashes to gastrointestinal issues. A certain percentage, however, have more than these uncomfortable symptoms to deal with. Anaphylaxis, a serious life-threatening reaction, causes approximately 1,500 deaths a year in the United States alone. Clearly, allergies are nothing to sneeze at!
Articles for Advocacy
Anaphylaxis: Future therapies look promising!
John Lee, MD, Director of the Food Allergy Program at Boston Children’s Hospital, gives us a detailed report on several new ways to administer epinephrine that are in development. Many people choose a method based on cost and what insurance will cover, but soon we will have many more options that have longer shelf lives and are easy to use. (“What’s in your wallet?”) We also offer an update on the peanut patch as a possible prevention method. You can read all the details here.
Dr. John Lee of AllergyHome.org discusses new future treatments
By Kristen Stewart
April 10th, 2016
From prefilled syringes in the 1960s to the advent of auto-injectors in 1980, epinephrine and its treatment for anaphylaxis has come a long way--but that doesn’t mean researchers are resting on their laurels. Not only are they busy exploring possible new innovations they are even making old ideas new again.
The Bacterial Imbalance Behind Food Allergies
Scientists continue to study causes of severe food allergies, and are getting closer to finding answers. One interesting study found that those with eczema are six times more likely to develop food allergies. Other causes being investigated are an overactive immune system at birth and overuse of antibiotics under the “hygiene hypothesis.” And then there is what may turn out to be the holy grail of allergy prevention— earlier consumption of peanuts by high-risk infants that has shown to dramatically decrease their risk of developing a peanut allergy.
An update on current research
By Conan Milner
March 27, 2016
Allergies are caused by an immune system gone haywire, reacting to substances that generally do not affect most people. For example, peanuts are typically harmless. But for those with a peanut allergy, ingestion can trigger a severe, even fatal, reaction.
Stock Epi Used in 38% of Anaphylactic Reactions in U.S. Schools
It’s great to know that past efforts to get legislation passed to allow epinephrine to be stocked in schools is saving lives. Of particular importance are those times it has been used on people who weren’t aware they had an allergy (25% of the 1,140 reactions in schools), and previously would have had no access to life-saving epinephrine. However the need for training remains as only one in three schools surveyed had taught their entire staff to recognize the signs and symptoms of a severe reaction.
Data shows improved student access to epinephrine saves lives!
By: Ishani Nath
March 20th, 2016
Each academic year, one in every six U.S. schools will have a student or staff member experience anaphylaxis, according to a nationwide survey that further supports the need for stock epinephrine auto-injectors in schools, and training for staff on when and how to use them.
May 4th, 2016 - FOOD ALLERGY & ANAPHYLAXIS AWARENESS DAY
Food Allergy & Anaphylaxis Awareness Day
Empire State Plaza
Visitor Parking S Mall Arteria
LOB lobby entrance
Albany, NY 12210
Wednesday, May 4, 9am - 5pm